Last €53.00 EUR
Change Today +1.22 / 2.36%
Volume 288.0
MRK On Other Exchanges
New York
EN Paris
Sao Paulo
As of 7:41 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Adam H. Schechter

President of Global Human Health and Executive Vice President, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Adam H. Schechter has been the President of Global Human Health and Executive Vice President at Merck & Co., Inc. since May 2010. Mr. Schechter served as President of Global Pharmaceuticals at Merck Frosst Canada Ltd., a subsidiary of Merck & Co. Inc. He served as the President of Global Pharmaceuticals of Merck & Co. Inc. since August 2007. He served as President of U.S. Human Health - commercial of Merck & Co. Inc. from July 2006 to August 2007. Mr. Schechter served ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

Director, Member of Compensation Committee and Member of Quality & Compliance Committee


BA 1986
La Salle University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$957,306

Stock Options*

Restricted Stock Awards$1,813,702
All Other Compensation$160,359
Exercisable Options474,289
Exercisable Options Value$5,416,417
Unexercisable Options517,086
Unexercisable Options Value$4,408,811
Total Value of Options$9,825,228
Total Number of Options991,375

Total Compensation*

Total Annual Cash Compensation$1,808,852
Total Short Term Compensation$957,306
Other Long Term Compensation$1,974,061
Total Calculated Compensation$5,142,557
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:FP €53.00 EUR +1.22


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at